A
36.35
0.39 (1.08%)
| Previous Close | 35.96 |
| Open | 35.76 |
| Volume | 194,607 |
| Avg. Volume (3M) | 401,337 |
| Market Cap | 1,740,579,584 |
| Price / Earnings (TTM) | 173.10 |
| Price / Earnings (Forward) | 57.47 |
| Price / Sales | 3.77 |
| Price / Book | 3.77 |
| 52 Weeks Range | |
| Earnings Date | 4 May 2026 |
| Profit Margin | -5.49% |
| Operating Margin (TTM) | -0.69% |
| Diluted EPS (TTM) | -0.510 |
| Quarterly Revenue Growth (YOY) | 1.60% |
| Total Debt/Equity (MRQ) | 123.15% |
| Current Ratio (MRQ) | 5.53 |
| Operating Cash Flow (TTM) | 10.78 M |
| Levered Free Cash Flow (TTM) | -14.03 M |
| Return on Assets (TTM) | 1.54% |
| Return on Equity (TTM) | -7.26% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Artivion, Inc. | Bullish | Bullish |
AIStockmoo Score
0.0
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.00 |
|
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 5.01% |
| % Held by Institutions | 98.14% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Juniper Investment Company, Llc | 31 Dec 2025 | 1,189,136 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 58.00 (Needham, 59.56%) | Buy |
| Median | 53.00 (45.81%) | |
| Low | 48.00 (Canaccord Genuity, 32.05%) | Buy |
| Average | 53.00 (45.81%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 38.92 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Canaccord Genuity | 13 Feb 2026 | 48.00 (32.05%) | Buy | 36.60 |
| Needham | 02 Feb 2026 | 58.00 (59.56%) | Buy | 41.23 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 02 Feb 2026 | Announcement | Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting |
| 29 Jan 2026 | Announcement | Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results |
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 09 Dec 2015 | 22 Oct 2015 | 18 Dec 2015 | 0.03 Cash |
| 09 Sep 2015 | 22 Jul 2015 | 18 Sep 2015 | 0.03 Cash |
| 10 Jun 2015 | 21 May 2015 | 19 Jun 2015 | 0.03 Cash |
| 11 Mar 2015 | 13 Feb 2015 | 20 Mar 2015 | 0.03 Cash |
| 10 Dec 2014 | 23 Oct 2014 | 19 Dec 2014 | 0.03 Cash |
| 10 Sep 2014 | 30 Jul 2014 | 19 Sep 2014 | 0.03 Cash |
| 11 Jun 2014 | 22 May 2014 | 20 Jun 2014 | 0.03 Cash |
| 12 Mar 2014 | 19 Feb 2014 | 21 Mar 2014 | 0.0275 Cash |
| 11 Dec 2013 | 21 Nov 2013 | 20 Dec 2013 | 0.0275 Cash |
| 11 Sep 2013 | 21 Aug 2013 | 20 Sep 2013 | 0.0275 Cash |
| 12 Jun 2013 | 28 May 2013 | 21 Jun 2013 | 0.0275 Cash |
| 12 Mar 2013 | 13 Feb 2013 | 21 Mar 2013 | 0.025 Cash |
| 12 Dec 2012 | 19 Nov 2012 | 21 Dec 2012 | 0.025 Cash |
| 12 Sep 2012 | 21 Aug 2012 | 21 Sep 2012 | 0.025 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2015 | 0.120 | 4 | 1.11 |
| 2014 | 0.118 | 4 | 1.04 |
| 2013 | 0.108 | 4 | 0.97 |
| 2012 | 0.050 | 2 | 0.80 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |